Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital

Salt Lake City, Utah 84112

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Acute Leukemia

Studies at this site

• Expanded Access Program for Revumenib — NO_LONGER_AVAILABLE